文献速递临床试验与 GCP流行病学与生物统计

极早产儿血氧饱和度目标范围与死亡或残疾的关联:NeOProM 前瞻性荟萃分析

Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration.
PubMed 文献 · JAMA · 2018-01-01

该研究对5项随机临床试验的个体参与者数据进行前瞻性计划荟萃分析,纳入胎龄不足28周的极早产儿,比较脉搏血氧饱和度目标范围85%-89%与91%-95%对死亡或主要残疾的影响。共有4965名婴儿随机分组,主要复合结局在两组间无显著差异,但较低目标范围与死亡和坏死性小肠结肠炎风险升高相关,而早产儿视网膜病变治疗风险较低。

要点

  • 较低与较高SpO2目标范围在死亡或主要残疾复合结局上无显著差异。
  • 较低目标范围与死亡风险升高及严重坏死性小肠结肠炎风险升高相关。
  • 较低目标范围与早产儿视网膜病变治疗风险降低相关。

核心结论

  • 在极早产儿中,较低与较高SpO2目标范围相比,校正年龄18至24个月时死亡或主要残疾复合结局无显著差异。
  • 较低SpO2目标范围与死亡和坏死性小肠结肠炎风险升高相关,但与早产儿视网膜病变治疗风险降低相关。

研究设计与样本

  • 研究设计为前瞻性计划荟萃分析,汇总5项随机临床试验(2005-2014年)的个体参与者数据。
  • 纳入胎龄不足28周的极早产儿,共4965名婴儿随机分组,较低目标组2480名,较高目标组2485名。
  • 中位胎龄26周(四分位距25-27周),平均出生体重832克(标准差190克)。

主要发现

  • 16项次要结局中11项无差异,2项显著 favoring 较低目标组,3项显著 favoring 较高目标组。

关键数值与推荐

  • SpO2目标范围:较低组85%-89%,较高组91%-95%。
  • 主要结局为校正年龄18至24个月时死亡或主要残疾复合结局(包括双侧失明、耳聋、粗大运动功能分类系统≥2级的脑瘫、Bayley-III认知或语言评分<85)。

临床怎么用

  • 临床对极早产儿设定SpO2目标范围时需权衡死亡、坏死性小肠结肠炎与早产儿视网膜病变的风险。
  • 不宜简单将SpO2目标统一设为较低范围,应结合个体情况并参考次要结局的异质性。

局限性

  • 原文摘要未报告各试验间异质性、盲法实施细节及长期随访完整性的具体信息。
  • 次要结局中方向不一致,需谨慎解读具体获益与危害的临床意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: There are potential benefits and harms of hyperoxemia and hypoxemia for extremely preterm infants receiving more vs less supplemental oxygen. OBJECTIVE: To compare the effects of different target ranges for oxygen saturation as measured by pulse oximetry (Spo2) on death or major morbidity. DESIGN, SETTING, AND PARTICIPANTS: Prospectively planned meta-analysis of individual participant data from 5 randomized clinical trials (conducted from 2005-2014) enrolling infants born before 28 weeks' gestation. EXPOSURES: Spo2 target range that was lower (85%-89%) vs higher (91%-95%). MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of death or major disability (bilateral blindness, deafness, cerebral palsy diagnosed as ≥2 level on the Gross Motor Function Classification System, or Bayley-III cognitive or language score <85) at a corrected age of 18 to 24 months. There were 16 secondary outcomes including the components of the primary outcome and other major morbidities. RESULTS: A total of 4965 infants were randomized (2480 to the lower Spo2 target range and 2485 to the higher Spo2 range) and had a median gestational age of 26 weeks (interquartile range, 25-27 weeks) and a mean birth weight of 832 g (SD, 190 g). The primary outcome occurred in 1191 of 2228 infants (53.5%) in the lower Spo2 target group and 1150 of 2229 infants (51.6%) in the higher Spo2 target group (risk difference, 1.7% [95% CI, -1.3% to 4.6%]; relative risk [RR], 1.04 [95% CI, 0.98 to 1.09], P = .21). Of the 16 secondary outcomes, 11 were null, 2 significantly favored the lower Spo2 target group, and 3 significantly favored the higher Spo2 target group. Death occurred in 484 of 2433 infants (19.9%) in the lower Spo2 target group and 418 of 2440 infants (17.1%) in the higher Spo2 target group (risk difference, 2.8% [95% CI, 0.6% to 5.0%]; RR, 1.17 [95% CI, 1.04 to 1.31], P = .01). Treatment for retinopathy of prematurity was administered to 220 of 2020 infants (10.9%) in the lower Spo2 target group and 308 of 2065 infants (14.9%) in the higher Spo2 target group (risk difference, -4.0% [95% CI, -6.1% to -2.0%]; RR, 0.74 [95% CI, 0.63 to 0.86], P < .001). Severe necrotizing enterocolitis occurred in 227 of 2464 infants (9.2%) in the lower Spo2 target group and 170 of 2465 infants (6.9%) in the higher Spo2 target group (risk difference, 2.3% [95% CI, 0.8% to 3.8%]; RR, 1.33 [95% CI, 1.10 to 1.61], P = .003). CONCLUSIONS AND RELEVANCE: In this prospectively planned meta-analysis of individual participant data from extremely preterm infants, there was no significant difference between a lower Spo2 target range compared with a higher Spo2 target range on the primary composite outcome of death or major disability at a corrected age of 18 to 24 months. The lower Spo2 target range was associated with a higher risk of death and necrotizing enterocolitis, but a lower risk of retinopathy of prematurity treatment.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Askie LM, Darlow BA, Finer N, et al. Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA. 2018. PMID: 29872859. doi:10.1001/jama.2018.5725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。